Dolasetron

DRUG3 trials

Sponsors

GlaxoSmithKline, University Hospital, Limoges, First Affiliated Hospital of Wenzhou Medical University

Conditions

FibromyalgiaNausea and Vomiting, Chemotherapy-Induced

Phase 1

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

CompletedNCT00511823

GlaxoSmithKlineNausea and Vomiting, Chemotherapy-Induced

Start: 2007-07-23End: 2007-09-21Updated: 2017-08-03

Phase 2

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

Not yet recruitingNCT06593782

First Affiliated Hospital of Wenzhou Medical UniversityNausea and Vomiting, Chemotherapy-Induced

Start: 2024-09-16End: 2025-09-01Target: 180Updated: 2024-09-19

Phase 3

Efficacy of Dolasetron in Patients With Fibromyalgia

CompletedNCT00820326

University Hospital, LimogesFibromyalgia

Start: 2004-03-31End: 2008-06-30Updated: 2025-07-16